TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE
6.1. Overview
6.2. Continuous Upstream Biomanufacturing
6.3. Single-Use Upstream Biomanufacturing
6.4. Downstream Biomanufacturing
7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION
7.1. Overview
7.2. Monoclonal Antibodies
7.3. Hormones
7.4. Vaccines
7.5. Recombinant Proteins
7.6. Others
8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER
8.1. Overview
8.2. Biopharmaceutical Companies
8.3. Research Institutions
8.4. CMOs/CDMOs
9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Next-Generation Biomanufacturing Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Next-Generation Biomanufacturing Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. Oxford Nanopore Technologies plc
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Illumina, Inc.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Thermo Fisher Scientific Inc.
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Qiagen N.V.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Agilent Technologies, Inc.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. BGI (China)
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. PerkinElmer Inc.
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. F. Hoffmann-La Roche Ltd
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Takara Bio Inc.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Eurofins Scientific
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 US: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 US: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 11 US: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 13 CANADA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 CANADA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 10 ITALY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 11 ITALY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 12 ITALY: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 16 UK: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 17 UK: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 UK: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 28 CHINA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 29 CHINA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 CHINA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 31 INDIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 INDIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 33 INDIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, BY END-USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET
FIGURE 4 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 6 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY END-USER, 2023
FIGURE 7 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: NEXT-GENERATION BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 OXFORD NANOPORE TECHNOLOGIES PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 OXFORD NANOPORE TECHNOLOGIES PLC: SWOT ANALYSIS
FIGURE 15 ILLUMINA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 ILLUMINA, INC.: SWOT ANALYSIS
FIGURE 17 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 19 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 QIAGEN N.V.: SWOT ANALYSIS
FIGURE 21 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 23 BGI (CHINA): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 BGI (CHINA): SWOT ANALYSIS
FIGURE 25 PERKINELMER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 PERKINELMER INC.: SWOT ANALYSIS
FIGURE 27 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 29 TAKARA BIO INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 TAKARA BIO INC.: SWOT ANALYSIS
FIGURE 31 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 EUROFINS SCIENTIFIC: SWOT ANALYSIS
